02617.HK
TransThera Sciences (Nanjing) Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 8.40
−2.95%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.23x
- Price / sales
- 81.09x
- Price / cash flow
- -19.63x
Enterprise value
- Enterprise value
- HKD 2.3B
- EV / sales
- 54.79x
- EV / EBITDA
- -7.16x
- EV / EBIT
- -4.83x
- Market cap
- HKD 3.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026